INTRODUCTION: Although gefitinib used for the treatment of non-small-cell lung cancer is a well-known cause of interstitial lung disease (ILD), few case reports on erlotinib-induced ILD have been issued.
interstitial lung disease
gefitinib
ILD
erlotinib
ILD
gefitinib